Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Diabetes

Free Subscription Articles published in J Diabetes Complications Retrieve available abstracts of 260 articles: HTML format

Single Articles

December 2025
1. AL-MHANNA SB, Franklin BA, Jakicic JM, Stamatakis E, et al
   Impact of aerobic exercise on cardiometabolic health in patients with diabesity: A systematic review and meta-analysis of randomized controlled trials.
   J Diabetes Complications. 2025;39:109203.
   PubMed     Abstract available
   
   
   
2. ZHAO C, Lu X, Deng X, Xia W, et al
   The effects of Bifidobacterium animalis subsp. lactis BLa80 on glycemic control and gut microbiota in patients with T2DM: a randomized, double-blind, placebo-controlled trial.
   J Diabetes Complications. 2025;39:109195.
   PubMed     Abstract available
   
   
   
3. SARI F, Bazancir-Apaydin Z, Sari S, Sari MC, et al
   Assessing the impact of dysphagia on quality of life and determining SWAL-QOL cut-off scores in diabetes mellitus patients: a data mining approach.
   J Diabetes Complications. 2025;39:109205.
   PubMed     Abstract available
   
   
   
4. AYDOGAN HY, Demirci DK, Gul N, Yanar F, et al
   Gender differences in the distribution of IDL, LDL, and HDL lipoprotein subfractions in MODY compared to type 2 diabetes: Data from the MODY-Ist study.
   J Diabetes Complications. 2025;39:109196.
   PubMed     Abstract available
   
   
   November 2025
5. GOLCHIN A, Johnson KC, Houston DK, Luchsinger JA, et al
   Associations of modifiable lifestyle and clinical factors with cognitive function in adults with type 2 diabetes.
   J Diabetes Complications. 2025;40:109227.
   PubMed     Abstract available
   
   
   
6. SLATER T, Hernandez Ibarburu G, Drebert Z, Henson J, et al
   Age at type 2 diabetes diagnosis and risk of cancer: Cohort study in over 1 million individuals from the TriNetX US Collaborative Network.
   J Diabetes Complications. 2025;40:109210.
   PubMed     Abstract available
   
   
   
7. QIN R, Jiang C, Zhang M, Hou X, et al
   Prognostic value of non-alcoholic fatty liver disease, pericoronary fat attenuation index and computed tomography-derived fractional flow reserve in diabetic patients with suspected coronary artery disease.
   J Diabetes Complications. 2025;40:109216.
   PubMed     Abstract available
   
   
   
8. BRIGANTI SI, Lanza O, Renzelli V, Campagna G, et al
   Impact of technologies on quality of life in relation to glucose control in patients with type 1 diabetes.
   J Diabetes Complications. 2025;40:109215.
   PubMed     Abstract available
   
   
   
9. AJONIJEBU TE, Mazibuko-Mbeje SE
   The miR-200 family in type 2 diabetes: therapeutic and biomarker perspectives.
   J Diabetes Complications. 2025;40:109211.
   PubMed     Abstract available
   
   
   
10. LIM S, Park CY, Jeong IK, Yoon JS, et al
    Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naive type 2 diabetes: The EMPA-FIT study.
    J Diabetes Complications. 2025;40:109214.
    PubMed     Abstract available
    
    
    
11. NISHIMURA M, Yonezawa K, Sawamura M, Tanaka T, et al
    Identification of biomarkers to predict renal function decline and its deceleration in patients with type 2 diabetes and diabetic kidney disease.
    J Diabetes Complications. 2025;40:109208.
    PubMed     Abstract available
    
    
    October 2025
12. JORGENSEN IL, Thuesen ACB, Clausen TD, Ringholm L, et al
    Glycemia, management and outcomes of pregnant women with maturity-onset diabetes of the young - a single-center case series.
    J Diabetes Complications. 2025;40:109206.
    PubMed     Abstract available
    
    
    
13. GUO J, Li Z, Carrillo-Larco RM, Hsia DS, et al
    Data-driven subtypes of newly diagnosed youth-onset type 2 diabetes in the USA.
    J Diabetes Complications. 2025;40:109207.
    PubMed     Abstract available
    
    
    
14. POHAN SD, Sauriasari R, Maggadani BP, Rukmana TI, et al
    Serum analysis of type 2 diabetes mellitus patients with low, moderate, and high risk of diabetic kidney disease using LC-MS metabolomics approach.
    J Diabetes Complications. 2025;40:109202.
    PubMed     Abstract available
    
    
    
15. ELHENAWY YI, Thabet RA, Hegazy MGA, El-Morsy SA, et al
    The role of oral alpha-lipoic acid as an adjuvant antioxidant therapy in diabetic nephropathy among children and adolescents with type 1 diabetes: a randomized controlled trial.
    J Diabetes Complications. 2025;40:109201.
    PubMed     Abstract available
    
    
    
16. MORONEY E, Niewczas MA, Ekinci EI, MacIsaac RJ, et al
    Soluble tumor necrosis factor receptors (sTNFRs) as biomarkers for diabetic kidney disease: Soluble TNF receptors and DKD.
    J Diabetes Complications. 2025;40:109204.
    PubMed     Abstract available
    
    
    
17. WISNIEWSKI A, DeMonte J, Sarteau AC, Fruik A, et al
    Levels of diabetes distress and its sources among older adults with type 1 diabetes and relationships to diabetes duration.
    J Diabetes Complications. 2025;39:109198.
    PubMed     Abstract available
    
    
    
18. ZUBIRIA JM, Molina E, Toledo E, Forga L, et al
    Association of matrix metalloproteinase-10 levels and genetic variant rs17860955 with severe vascular complications in patients with type 1 diabetes: prospective cohort.
    J Diabetes Complications. 2025;39:109200.
    PubMed     Abstract available
    
    
    
19. ABDELHAFIZ AH, Siqueira I, Sinclair AJ
    Criteria of frail older people with type 2 diabetes who are suitable for SGLT-2 inhibitors and GLP-1RA therapy.
    J Diabetes Complications. 2025;39:109193.
    PubMed     Abstract available
    
    
    
20. ZHOU Q, Yang H, Xie XS, Wang RD, et al
    Gestational diabetes mellitus and the subsequent risk of chronic kidney disease: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109197.
    PubMed     Abstract available
    
    
    
21. BANERJEE S, Khubchandani J, Gonzales-Lagos R
    Diabetes, anxiety, and mortality risk among middle and older-aged Americans.
    J Diabetes Complications. 2025;39:109194.
    PubMed     Abstract available
    
    
    
22. ANGELOPOULOS N, Livadas S, Androulakis I, Petkova V, et al
    Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.
    J Diabetes Complications. 2025;39:109181.
    PubMed     Abstract available
    
    
    
23. CANGELOSI G, Sacchini F, Mancin S, Morales Palomares S, et al
    Response to: "Letter to the editor "The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review".
    J Diabetes Complications. 2025 Oct 6:109180. doi: 10.1016/j.jdiacomp.2025.109180
    PubMed    
    
    
    
24. CHRISTENSEN MMB, Hansen CS, Fleischer J, Senftleber N, et al
    The prevalence of diabetic neuropathy in Greenland and its association with Inuit genetic ancestry - a cross-sectional study.
    J Diabetes Complications. 2025;39:109179.
    PubMed     Abstract available
    
    
    
25. FRALICK M, Hojbjerg Lassen MC, Rangrej J, Asgari S, et al
    Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study.
    J Diabetes Complications. 2025;39:109144.
    PubMed     Abstract available
    
    
    
26. KYKKANEN E, Kaartinen I, Arponen O, Vuorlaakso M, et al
    Low imaging-detected muscle mass as a prognostic factor for overall and amputation-free survival in patients undergoing lower extremity amputation.
    J Diabetes Complications. 2025;39:109119.
    PubMed     Abstract available
    
    
    September 2025
27. CHEN KY, Chan HC, Chan CM
    Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety.
    J Diabetes Complications. 2025;39:109178.
    PubMed     Abstract available
    
    
    
28. SAMBATARO M, Sambado L, Colardo M, Furlan A, et al
    Neuroinflammation and osteomyelitis in adults with Type 2 diabetes mellitus and peripheral neuropathy without and with foot lesions. What comes first?
    J Diabetes Complications. 2025;39:109176.
    PubMed     Abstract available
    
    
    
29. HOFFMANN K, Paczkowska A, Maggio V, Rizzo M, et al
    The cardiovascular-kidney-metabolic staging in type 2 diabetes: the clock starts ticking early.
    J Diabetes Complications. 2025;39:109177.
    PubMed     Abstract available
    
    
    
30. RIZK MA, El-Haggar SM, Ibrahim OM, Ghazi HA, et al
    Efficacy of levocetirizine in reducing albuminuria and inflammatory biomarkers in patients with diabetic kidney disease: A randomized controlled trial.
    J Diabetes Complications. 2025;39:109175.
    PubMed     Abstract available
    
    
    
31. XIE Z, Liang Z, Zheng G, Cao W, et al
    A comparative analysis of cost-utility: Chiglitazar vs. sitagliptin in patients with type 2 diabetes in China.
    J Diabetes Complications. 2025;39:109174.
    PubMed     Abstract available
    
    
    
32. PATEL D, Shah AS, Magella B, Bahrainian M, et al
    High rate of complications in a real-world cohort of youth with T2D: a multicenter analysis.
    J Diabetes Complications. 2025;39:109091.
    PubMed     Abstract available
    
    
    
33. FANG Y, Jing L, Zhu Y, Wang H, et al
    Relationship between flow-mediated dilation and urinary albumin-creatinine ratio in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2025;39:109162.
    PubMed     Abstract available
    
    
    August 2025
34. JOHNSON TM, Churilla JR
    Trends in mean serum insulin and hyperinsulinemia among US adults without diabetes 1999-2018.
    J Diabetes Complications. 2025;39:109159.
    PubMed     Abstract available
    
    
    
35. VAIDYA D, Yeboah-Kordieh Y, Howard M, Hugenschmidt CE, et al
    Sex specific associations of sex hormones with brain volumes and cerebral blood flow: A cross sectional observational study within the look AHEAD type 2 diabetes cohort.
    J Diabetes Complications. 2025;39:109161.
    PubMed     Abstract available
    
    
    
36. JAMES S, Barber R, Forster J, Sawatsky L, et al
    Atypical complications and co-morbidities of type 1 diabetes in young adults.
    J Diabetes Complications. 2025;39:109158.
    PubMed     Abstract available
    
    
    
37. HERMAN WH, Villatoro C, Joiner KL, McEwen LN, et al
    Corrigendum to "Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience" [J. Diabetes Complicat. (2023) 108527].
    J Diabetes Complications. 2025 Aug 26:109157.
    PubMed    
    
    
    
38. JI L, Abudulam R, Li M
    Letter to the Editor "The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review".
    J Diabetes Complications. 2025 Aug 25:109155.
    PubMed    
    
    
    
39. KIM J, Bae S, Yun D, Park S, et al
    Clinical outcomes of and risk factors for normoalbuminuric diabetic kidney disease.
    J Diabetes Complications. 2025;39:109154.
    PubMed     Abstract available
    
    
    
40. WANG X, Yang S
    Letter to "Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study".
    J Diabetes Complications. 2025 Aug 21:109156.
    PubMed    
    
    
    
41. SCHMITTLING KA
    Risk assessment modeling for diabetes-related lower extremity amputation using socioeconomic and behavioral health indicators.
    J Diabetes Complications. 2025;39:109153.
    PubMed     Abstract available
    
    
    
42. HJORTKJAER HO, Rossing P, Kofoed KF
    Burden and progression of arterial calcification in type 1 diabetes predicts future cardiovascular disease.
    J Diabetes Complications. 2025;39:109152.
    PubMed     Abstract available
    
    
    
43. TIAN J, Zhao C, Li Y, Han Y, et al
    The impact of glycemic variability on the 28-day prognosis of patients with cardiogenic shock with or without diabetes mellitus: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109151.
    PubMed     Abstract available
    
    
    
44. WATANABE K, Nishioka H, Takubo M, Kosuda M, et al
    Pericardial fat pad detected on chest X-ray is closely associated with metabolic dysfunction-associated steatotic liver disease and visceral fat accumulation in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109150.
    PubMed     Abstract available
    
    
    
45. CHEN KY, Chan HC, Chan CM
    Is there a link between dry eye disease and diabetes mellitus? A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109149.
    PubMed     Abstract available
    
    
    
46. MUZUROVIC E, Topic G, Todorovic N, Rizzo M, et al
    The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.
    J Diabetes Complications. 2025;39:109147.
    PubMed     Abstract available
    
    
    July 2025
47. NISHIZAWA K, Tanaka M, Sato T, Gohda T, et al
    The health stage of cardiovascular-kidney-metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapy.
    J Diabetes Complications. 2025;39:109146.
    PubMed     Abstract available
    
    
    
48. BOMBACI B, Passanisi S, Longo A, Aramnejad S, et al
    The interplay between psychological well-being, diabetes-related distress, and glycemic control: A continuous glucose monitoring analysis from a population of adolescents with type 1 diabetes.
    J Diabetes Complications. 2025;39:109142.
    PubMed     Abstract available
    
    
    
49. BAIER JM, Funck KL, Vernstrom L, Gullaksen S, et al
    Effect of colchicine on platelet aggregation in patients with type 2 diabetes: Results from a randomized placebo-controlled trial.
    J Diabetes Complications. 2025;39:109141.
    PubMed     Abstract available
    
    
    
50. SACCHINI F, Mancin S, Cangelosi G, Palomares SM, et al
    The role of artificial intelligence in diabetic retinopathy screening in type 1 diabetes: A systematic review.
    J Diabetes Complications. 2025;39:109139.
    PubMed     Abstract available
    
    
    
51. YANG Z, Zheng B, Luo G, Xin X, et al
    Associations of time in range and glycemic risk index with insulin resistance and diabetic kidney disease in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109140.
    PubMed     Abstract available
    
    
    
52. YE J, Qin Y, Zhao L, Yang L, et al
    Relationship between relative fat mass and coronary artery calcification in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109133.
    PubMed     Abstract available
    
    
    
53. MARIA AURORA RW, Paolo P
    What type 1 diabetes endotype is most suitable for anti-CD3 antibodies prevention trials?
    J Diabetes Complications. 2025;39:109132.
    PubMed     Abstract available
    
    
    
54. VEZINA-IM LA, Turcotte AF, Messier V, Turcotte S, et al
    BETTER sleep: Sleep quality among adults living with type 1 diabetes in Canada.
    J Diabetes Complications. 2025;39:109137.
    PubMed     Abstract available
    
    
    
55. ZHENG D, Cui C
    Elevated small dense low-density lipoprotein-cholesterol as a risk factor for lower extremity arterial disease in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2025;39:109136.
    PubMed     Abstract available
    
    
    
56. DISSANAYAKE HA, Kiire CA, Preiss D, Tan GD, et al
    The use of fenofibrate in diabetic retinopathy: Narrative review.
    J Diabetes Complications. 2025;39:109135.
    PubMed     Abstract available
    
    
    
57. DE OLIVEIRA HM, Gallo Ruelas M, Flavio-Reis VHP, Queiroz I, et al
    Degludec insulin versus efsitora insulin in diabetes mellitus management: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109115.
    PubMed     Abstract available
    
    
    
58. HUBER SL, Parzer V, Ludvik B, Pollreisz A, et al
    Evaluation of IDx-DR software for diabetic retinopathy screening in outpatient clinics: Efficacy, safety, and feasibility in a real-world setting.
    J Diabetes Complications. 2025;39:109120.
    PubMed     Abstract available
    
    
    
59. ZHANG Z, Yang R, Wu W, Wang Z, et al
    Association of aortic pulse wave velocity with cardiovascular outcomes and all-cause mortality in diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109118.
    PubMed     Abstract available
    
    
    
60. LIU Y, Yue J, Jiang Y, Tian X, et al
    The role of circRNA in insulin resistance and its progression induced by adipose inflammation.
    J Diabetes Complications. 2025;39:109042.
    PubMed     Abstract available
    
    
    June 2025
61. COWART K, Murphy C, Carris N
    Association of tirzepatide with erectile dysfunction in people with type 2 diabetes.
    J Diabetes Complications. 2025;39:109116.
    PubMed     Abstract available
    
    
    
62. DAVILA-GARCIA DM, Falconer T, Pratt N, Natarajan K, et al
    Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence.
    J Diabetes Complications. 2025;39:109114.
    PubMed     Abstract available
    
    
    
63. OZGUMUS T, Sulaieva O, Begum MC, Ekstrom O, et al
    DNA repair and inflammatory response genes play a central role in protecting patients with long-standing type 1 diabetes from vascular complications.
    J Diabetes Complications. 2025;39:109112.
    PubMed     Abstract available
    
    
    
64. CARRIS NW, Mhaskar R, Coughlin E, Bracey E, et al
    A mediation analysis assessing if interleukin-6 mediates the association between obesity and new-onset type-2-diabetes.
    J Diabetes Complications. 2025;39:109110.
    PubMed     Abstract available
    
    
    
65. PALBRINK AK, Magnusson M, Degerman E
    Modulation of the sodium-chloride cotransporter by insulin in auditory cells: A potential link to diabetes-related hearing complications.
    J Diabetes Complications. 2025;39:109111.
    PubMed     Abstract available
    
    
    
66. SANTOS VKJD, Prado MLL, Da Silva GSN, Sant'anna Aragao IC, et al
    Technosphere insulin in the treatment of Type 1 diabetes mellitus: A systematic review and meta-analysis.
    J Diabetes Complications. 2025;39:109108.
    PubMed     Abstract available
    
    
    
67. TAL N, Hershkowitz I, Gorin K, Leibovitch M, et al
    Clinical outcomes of patients with Polyvascular disease admitted with an acute diabetic foot ulcer.
    J Diabetes Complications. 2025;39:109109.
    PubMed     Abstract available
    
    
    
68. GALIERO R, Rezki A, Simeon V, Beccia D, et al
    NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy.
    J Diabetes Complications. 2025;39:109107.
    PubMed     Abstract available
    
    
    
69. SULTAN S, Sabeeh R
    Impact of gestational and type 2 diabetes on fetal endothelial cell miRNA expression.
    J Diabetes Complications. 2025;39:109106.
    PubMed     Abstract available
    
    
    
70. QUADRA MR, Schafer AA, Meller FO, Martins CD, et al
    Relationship between body fat and cognitive function in individuals with diabetes mellitus.
    J Diabetes Complications. 2025;39:109105.
    PubMed     Abstract available
    
    
    May 2025
71. FAN J, Zuo L, Liu X, Tang Y, et al
    Incremental value of CT-based perirenal fat characteristics in the categorization and progression prediction of diabetic kidney disease.
    J Diabetes Complications. 2025;39:109104.
    PubMed     Abstract available
    
    
    
72. JLALI I, Touil I, Amor HH, Tagougui S, et al
    Impaired cerebral hemodynamics and oxygenation in type 2 diabetes: insights into insulin resistance and hyperglycemia effects.
    J Diabetes Complications. 2025;39:109102.
    PubMed     Abstract available
    
    
    
73. YILDIRIM AT, Bayar NTI, Yigit Y, Ersoy B, et al
    The role of biomarkers of innate and adaptive immunity in the early detection of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus.
    J Diabetes Complications. 2025;39:109090.
    PubMed     Abstract available
    
    
    
74. EIN-GAL Y, Aharon-Hananel G, Sigawi T, Hamtzany O, et al
    A national quality survey of in-patient diabetic foot care calls for centralizing care and improving patient communication.
    J Diabetes Complications. 2025;39:109088.
    PubMed     Abstract available
    
    
    
75. SOTO-HERNAEZ J, McCrimmon RJ, Pearson ER, Soto-Pedre E, et al
    Real-world initiation of continuous glucose monitoring (CGM) in adults with type 1 diabetes leads to increased body mass index - A brief report from IMI-SOPHIA study.
    J Diabetes Complications. 2025;39:109089.
    PubMed     Abstract available
    
    
    
76. SEBASTIAN-VALLES F, Santiago-Redondo A, Garcia-Artacho E, Sampedro-Nunez MA, et al
    Impact of remnant cholesterol and triglycerides on diabetes foot and disease in type 1 diabetes: A propensity score-matched case-control study.
    J Diabetes Complications. 2025;39:109082.
    PubMed     Abstract available
    
    
    
77. UBERALL MA, Kender Z, Quandel T, Engelen S, et al
    Progressive improvements in patient-reported outcomes with the high-concentration capsaicin patch: A retrospective cohort study in patients with painful diabetic peripheral neuropathy (CASPAR study).
    J Diabetes Complications. 2025;39:109085.
    PubMed     Abstract available
    
    
    
78. PAPANAS N, Tsimihodimos V, Katsiki N, Doupis J, et al
    Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study).
    J Diabetes Complications. 2025;39:109087.
    PubMed     Abstract available
    
    
    
79. SCHMIDT CB, Keijsper E, Bosmans JE, van Loon BJP, et al
    Medical costs and health care utilization in Dutch diabetes patients with high levels of diabetes-distress.
    J Diabetes Complications. 2025;39:109086.
    PubMed     Abstract available
    
    
    
80. TILLQVIST H, Vuorlaakso M, Helminen M, Kiiski J, et al
    Clinical frailty scale as a tool to predict outcomes after lower extremity amputation among patients with diabetes: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109084.
    PubMed     Abstract available
    
    
    
81. PLAITANO EG, Stanger C
    Joint effect of nicotine use and diabetes distress on glycemic control in young adults with type 1 diabetes.
    J Diabetes Complications. 2025;39:109083.
    PubMed     Abstract available
    
    
    
82. PRIESTERROTH LS, Grammes J, Kubiak T
    Subtypes of disordered eating and their diabetes-related and psychosocial concomitants in adults with type 1 diabetes.
    J Diabetes Complications. 2025;39:109067.
    PubMed     Abstract available
    
    
    
83. IWAMOTO T, Morita M, Hidaka S, Sada K, et al
    Differential impact of short-term and long-term glycemic variability on peripheral nerve function in type 2 diabetes: A 5-year cohort study.
    J Diabetes Complications. 2025;39:109081.
    PubMed     Abstract available
    
    
    
84. LAN NSR, Hiew J, Ferreira I, Ritter JC, et al
    Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration.
    J Diabetes Complications. 2025;39:109069.
    PubMed     Abstract available
    
    
    
85. MAJD Z, Chen H, Johnson ML, Birtcher KK, et al
    Effect of initial combination therapy vs. step-therapy on adherence and persistence in drug naive type 2 diabetes patients.
    J Diabetes Complications. 2025;39:109080.
    PubMed     Abstract available
    
    
    
86. NORLEN T, Olesen TB, Domazet SL, Nielsen JS, et al
    Physical activity and albuminuria in individuals recently diagnosed with type 2 diabetes.
    J Diabetes Complications. 2025;39:109065.
    PubMed     Abstract available
    
    
    
87. MIYOSHI K, Aoyama T, Kameda S, Ishibashi N, et al
    Age different effects of SGLT2 inhibitors on body composition in individuals with type 2 diabetes: A retrospective cohort study.
    J Diabetes Complications. 2025;39:109068.
    PubMed     Abstract available
    
    
    
88. PERTILE P, D'Ippolito I, De Santis B, Andreadi A, et al
    External validation of a clinical risk score for the presence of cardiovascular autonomic neuropathy in type 1 diabetes.
    J Diabetes Complications. 2025;39:109066.
    PubMed     Abstract available
    
    
    
89. LI Q, Zhang M, Gao Q, Chen X, et al
    High fat-induced the upregulation of LOX-1 in RF/6A cells under high glucose condition.
    J Diabetes Complications. 2025;39:109019.
    PubMed     Abstract available
    
    
    April 2025
90. AL HAYEK A, Klonoff DC, Al Zahrani WM, Ibrahim SE, et al
    Evaluating the effect of Semaglutide as add-on therapy on glycemic control and continuous glucose monitoring outcomes in adults with type 1 diabetes: A two-year real-world data study.
    J Diabetes Complications. 2025;39:109064.
    PubMed     Abstract available
    
    
    
91. KIYAK-KIRMACI H, Hazar-Yavuz AN, Polat EB, Alsaadoni H, et al
    Effects of empagliflozin and dapagliflozin, SGLT2 inhibitors, on miRNA expressions in diabetes-related cardiovascular damage in rats.
    J Diabetes Complications. 2025;39:109063.
    PubMed     Abstract available
    
    
    
92. SHINOUCHI R, Shibata K, Nagatsuka T, Hasumi K, et al
    Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse model.
    J Diabetes Complications. 2025;39:109061.
    PubMed     Abstract available
    
    
    
93. BARBARESKO J, Lang A, Schiemann TB, Schaefer E, et al
    Dietary factors and cancer outcomes in individuals with type 2 diabetes: A systematic review and meta-analysis of prospective observational studies.
    J Diabetes Complications. 2025;39:109060.
    PubMed     Abstract available
    
    
    
94. SIDDIQI TJ, Liu Y, Zannad F, Tang WHW, et al
    Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF.
    J Diabetes Complications. 2025;39:109059.
    PubMed     Abstract available
    
    
    
95. COLACCI M, Raudanskis A, Fralick M
    Response to letter to the editor by Lai-Ming Kathleen Pak et al on: Identifying predictors of SGLT2 inhibitor and GLP1R agonist use in hospital among adults with diabetes.
    J Diabetes Complications. 2025 Apr 23:109046.
    PubMed    
    
    
    
96. PENNISI G, Petta S, Maggio V, Rizzo M, et al
    GLP-1 receptor agonists and MASLD in diabetes: A promising path?
    J Diabetes Complications. 2025 Apr 22:109041.
    PubMed    
    
    
    
97. SOLTANI P, Almeida FM, Melo HCC, Ferreira GBS, et al
    Body-weight functional exercise promotes greater and safer blood glucose reduction compared to aerobic and strength exercises in type 1 diabetics: a randomised crossover study.
    J Diabetes Complications. 2025;39:109043.
    PubMed     Abstract available
    
    
    
98. VOZIKI D, Dimakopoulos G, Stergiou I, Zografou I, et al
    The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes.
    J Diabetes Complications. 2025;39:109044.
    PubMed     Abstract available
    
    
    
99. GULLAKSEN S, Vernstrom L, Sorensen SS, Funck KL, et al
    Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial.
    J Diabetes Complications. 2025;39:109039.
    PubMed     Abstract available
    
    
    
100. WEINGARTEN SJ, Levy AT, Al-Kouatly HB, McLaren RA Jr, et al
     Postpartum diabetes mellitus among patients with early gestational diabetes: A systematic review and meta-analysis.
     J Diabetes Complications. 2025;39:109038.
     PubMed     Abstract available
     
     
     
101. ZHANG X, Wang Y, Zhao H, Chen S, et al
     A retrospective study to investigate the risk factors for gestational diabetes mellitus and its impact on maternal and neonatal outcomes.
     J Diabetes Complications. 2025;39:109035.
     PubMed     Abstract available
     
     
     
102. SHORA HA, El-Deen IM, El-Lithy NM, Abo-Elmatty DM, et al
     Growth differentiation factor-15: A marker for diabetic kidney disease in patients with metabolic-associated fatty liver disease.
     J Diabetes Complications. 2025;39:109037.
     PubMed     Abstract available
     
     
     
103. ASENSIO-SANCHEZ VM
     Comments on the article "the association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier ".
     J Diabetes Complications. 2025;39:108948.
     PubMed    
     
     
     
104. PAK LK, Le MV, Kevat D, Barmanray R, et al
     Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 agonist use in hospital among adults with diabetes.
     J Diabetes Complications. 2025 Apr 3:109022. doi: 10.1016/j.jdiacomp.2025.109022
     PubMed    
     
     
     
105. KING J, Buschur E, Garcetti R, Pyle L, et al
     Changes to insulin pump settings throughout pregnancy for individuals using assisted hybrid closed-loop therapy versus sensor-augmented pump therapy.
     J Diabetes Complications. 2025;39:109000.
     PubMed     Abstract available
     
     
     
106. PAPA G, Cannarella R, Finocchiaro C, Anzaldi M, et al
     Impact of automated insulin delivery (AID) systems on quality of life (QoL): Validation of the AID-QoL questionnaire.
     J Diabetes Complications. 2025;39:108984.
     PubMed     Abstract available
     
     
     March 2025
107. ZHANG W, Sun C, Huang Y, Zhang M, et al
     Inflammation levels in type 2 diabetes mellitus patients with mild cognitive impairment: Assessment followed by amelioration via dapagliflozin therapy.
     J Diabetes Complications. 2025;39:109017.
     PubMed     Abstract available
     
     
     
108. OZEL HF, Alpay S, Asker E, Gultekin ES, et al
     SGLT-2 inhibitors on cardiac autonomic function in individuals with and without type 2 diabetes mellitus.
     J Diabetes Complications. 2025;39:109021.
     PubMed     Abstract available
     
     
     
109. ANASTASIOU G, Maggio V, Rizzo M, Liberopoulos E, et al
     Lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy.
     J Diabetes Complications. 2025 Mar 26:109020.
     PubMed    
     
     
     
110. VAS PRJ, Maggio V, Rizzo M, Papanas N, et al
     Diabetic neuropathy in adolescents and young adults: The need for early detection and improved understanding.
     J Diabetes Complications. 2025 Mar 24:109018.
     PubMed    
     
     
     
111. KERR M, Wild D, Edmonds M, Boulton AJM, et al
     Cost effectiveness of topical wound oxygen therapy for chronic diabetic foot ulcers.
     J Diabetes Complications. 2025;39:109016.
     PubMed     Abstract available
     
     
     
112. FOJAS EG, Haidery A, Naseeb S, Naemi R, et al
     Type 2 diabetes and cardiovascular conditions prediction in individuals with metabolic syndrome-associated lipoprotein lipase gene (LPL) single nucleotide polymorphisms (SNPs).
     J Diabetes Complications. 2025;39:109003.
     PubMed     Abstract available
     
     
     
113. DEL ZOPPO A, Rovera C, Petralli G, Moriconi D, et al
     Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation.
     J Diabetes Complications. 2025;39:109015.
     PubMed     Abstract available
     
     
     
114. GKIOURTZIS N, Stoimeni A, Michou P, Cheirakis K, et al
     The NGAL as a prognostic biomarker of kidney injury in children and adolescents with type 1 diabetes mellitus: A systematic review and meta-analysis.
     J Diabetes Complications. 2025;39:109002.
     PubMed     Abstract available
     
     
     
115. WULANDARI N, Lamuri A, van Hasselt F, Feenstra T, et al
     The burden of depression among patients with type 2 diabetes: An umbrella review of systematic reviews.
     J Diabetes Complications. 2025;39:109004.
     PubMed     Abstract available
     
     
     
116. AHN J, Shahriarirad R, Kwon K, Bejarano-Pineda L, et al
     Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study.
     J Diabetes Complications. 2025;39:109001.
     PubMed     Abstract available
     
     
     
117. OLIVEIRA SB, Silveira ALPA, Kim YJ, do Amaral JB, et al
     Effect of non-surgical treatment in diabetes-associated periodontitis on immune/inflammatory and oxidative stress biomarkers: A pilot study.
     J Diabetes Complications. 2025;39:108999.
     PubMed     Abstract available
     
     
     
118. SEO JE, Rizzo M, Powell-Wiley TM
     Integrating social determinants of health into global approaches to early-onset type 2 diabetes.
     J Diabetes Complications. 2025;39:108982.
     PubMed    
     
     
     
119. JIN M, Bao Z, Hong X, He S, et al
     The prognostic value of the stress hyperglycemia ratio for all-cause mortality in stroke patients with diabetes or prediabetes.
     J Diabetes Complications. 2025;39:108979.
     PubMed     Abstract available
     
     
     
120. LIU L, Deng Y, Yang L, Wang M, et al
     Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis.
     J Diabetes Complications. 2025;39:108998.
     PubMed     Abstract available
     
     
     
121. ROLLINS J, Hong AL, Schroader B, Kong SX, et al
     Guideline-directed medical therapies (GDMTs) for chronic kidney disease with type 2 diabetes (CKD + T2D): Translation of lessons learned from the management of heart failure.
     J Diabetes Complications. 2025;39:108985.
     PubMed     Abstract available
     
     
     
122. ZARAGOZA-GARCIA O, Briceno O, Villafan-Bernal JR, Rojas-Delgado HU, et al
     sCD14 as a biomarker for the progression of kidney disease among patients with diabetes.
     J Diabetes Complications. 2025;39:108980.
     PubMed     Abstract available
     
     
     February 2025
123. HA KH, Kim W, Kim DH, Kim DJ, et al
     Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study.
     J Diabetes Complications. 2025;39:108983.
     PubMed     Abstract available
     
     
     
124. LIU R, Qu Z, Feng Y, Bai L, et al
     Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i.
     J Diabetes Complications. 2025;39:108981.
     PubMed     Abstract available
     
     
     
125. VAN BEURDEN W, Mendoza YP, Lange NF, Bosch J, et al
     FIB-4 predicts events in compensated advanced chronic liver disease and type 2 diabetes treated with GLP-1-receptor-agonists.
     J Diabetes Complications. 2025;39:108978.
     PubMed     Abstract available
     
     
     
126. LEE JC, Chong JW, Kumar S
     Highlighting the complex relationship between diabetes, renal function and bone health.
     J Diabetes Complications. 2025;39:108974.
     PubMed    
     
     
     
127. XU Q, Qiu X, Di H, Li Z, et al
     Liraglutide improves senescence and ameliorating diabetic sarcopenia via the YAP-TAZ pathway.
     J Diabetes Complications. 2025;39:108975.
     PubMed     Abstract available
     
     
     
128. PATANI K, Joharapurkar A, Sundar R, Kshirsagar S, et al
     Pharmacological effect of ZYGK1, a novel glucokinase activator, in hyperglycemic and sulfonylurea-resistant type 2 diabetes in mice models.
     J Diabetes Complications. 2025;39:108977.
     PubMed     Abstract available
     
     
     
129. ZHANG XY, Xu YX, Xue SQ, Zeng YQ, et al
     Oral edaravone ameliorates myocardial fibrosis in type 2 diabetic rats by TGF-beta1/Smad signaling pathway.
     J Diabetes Complications. 2025;39:108976.
     PubMed     Abstract available
     
     
     
130. MACKAY K, Thompson R, Parker M, Pedersen J, et al
     The role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers - A literature review.
     J Diabetes Complications. 2025;39:108973.
     PubMed     Abstract available
     
     
     
131. HOUGHTON JM, Hynes MC, Roberts NW, van der Westhuizen HM, et al
     Implementation of evidence-based foot screening in people with diabetes: A scoping review.
     J Diabetes Complications. 2025;39:108972.
     PubMed     Abstract available
     
     
     
132. ROSIEN L, Bilo HJG, Oskam J, Ruwaard D, et al
     Long-term mortality rates after lower extremity amputation in individuals with and without diabetes mellitus (DUDE-10): A retrospective matched cohort study.
     J Diabetes Complications. 2025;39:108956.
     PubMed     Abstract available
     
     
     
133. HIRANO Y, Tsuriya D, Kono K, Fujikura T, et al
     Association between muscle fatigability and diabetic kidney disease complications in patients with type 2 diabetes.
     J Diabetes Complications. 2025;39:108955.
     PubMed     Abstract available
     
     
     
134. DING T, Song M, Wang S, Huang C, et al
     Dapagliflozin has protective effects on palmitate-induced renal tubular epithelial cells by enhancing mitochondrial function and reducing oxidative stress.
     J Diabetes Complications. 2025;39:108930.
     PubMed     Abstract available
     
     
     January 2025
135. GAO H, Chen S, Li J, Liu Y, et al
     Elaboration and verification of immune-based diagnostic biomarker panel for diabetic foot ulcer.
     J Diabetes Complications. 2025;39:108957.
     PubMed     Abstract available
     
     
     
136. OKORO FO, Markus V
     Artificial sweeteners and Type 2 Diabetes Mellitus: A review of current developments and future research directions.
     J Diabetes Complications. 2025;39:108954.
     PubMed     Abstract available
     
     
     
137. MOH MC, Low S, Pek SLT, Liu JJ, et al
     Association of dysfunctional adiposity index with kidney impairment is accounted for by pigment epithelium-derived factor in type 2 diabetes mellitus - An 11-year follow-up of the SMART2D cohort study.
     J Diabetes Complications. 2025;39:108953.
     PubMed     Abstract available
     
     
     
138. YANG Y, Li F, Li Y, Li X, et al
     Nicotinamide n-methyltransferase inhibitor synergizes with sodium-glucose cotransporter 2 inhibitor to protect renal tubular epithelium in experimental models of type 2 diabetes mellitus.
     J Diabetes Complications. 2025;39:108952.
     PubMed     Abstract available
     
     
     
139. HE Y, Ye M, Shen Z, Zhong Z, et al
     Correlation between lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: A cross-sectional study.
     J Diabetes Complications. 2025;39:108950.
     PubMed     Abstract available
     
     
     
140. SCHMITTLING KA
     Behavioral health comorbidities in hospital outcomes post-lower extremity amputation in patients with type 1 and type 2 diabetes.
     J Diabetes Complications. 2025;39:108949.
     PubMed     Abstract available
     
     
     
141. YARIBEYGI H, Kashian K, Moghaddam KI, Karim SR, et al
     Hepatic effects of GLP-1 mimetics in diabetic milieu: A mechanistic review of involved pathways.
     J Diabetes Complications. 2025;39:108928.
     PubMed     Abstract available
     
     
     
142. SIDRA FNU, Agarwal S, Lockhart Pastor P, Xie D, et al
     Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy.
     J Diabetes Complications. 2025;39:108925.
     PubMed     Abstract available
     
     
     
143. LEE H, Hartfield PJ, Thorgerson A, Sinson GP, et al
     Cambridge risk score, new hyperglycemia, and complications in surgical patients without diabetes.
     J Diabetes Complications. 2025;39:108926.
     PubMed     Abstract available
     
     
     December 2024
144. LIU S, Ke J, Feng X, Xu Y, et al
     Diabetic microvascular complications are associated with left ventricular hypertrophy in patients with type 2 diabetes mellitus.
     J Diabetes Complications. 2024;39:108947.
     PubMed     Abstract available
     
     
     
145. BARMPAGIANNI A, Karamanakos G, Anastasiou IA, Kountouri A, et al
     The relationship between residual insulin secretion and subclinical cardiovascular risk indices in young adults with type 1 diabetes.
     J Diabetes Complications. 2024;39:108946.
     PubMed     Abstract available
     
     
     
146. RAUDANSKIS A, Sarma S, Biering-Sorensen T, Zorcic K, et al
     Identifying predictors of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonist use in hospital among adults with diabetes.
     J Diabetes Complications. 2024;39:108945.
     PubMed     Abstract available
     
     
     
147. ADDINGTON KS, Kristiansen M, Hempler NF, Frimodt-Moller M, et al
     Incidence of early-onset type 2 diabetes and sociodemographic predictors of complications: A nationwide registry study.
     J Diabetes Complications. 2024;39:108942.
     PubMed     Abstract available
     
     
     
148. OSMAN AAM, Seres-Bokor A, Ducza E
     Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications.
     J Diabetes Complications. 2024;39:108941.
     PubMed     Abstract available
     
     
     
149. REN R, Pei Y, Kong L, Shi Y, et al
     The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease.
     J Diabetes Complications. 2024;39:108932.
     PubMed     Abstract available
     
     
     
150. HAUGE SC, Hjortkjaer HO, Persson F, Theilade S, et al
     Bone mineral density and the risk of kidney disease in patients with type 1 diabetes.
     J Diabetes Complications. 2024;39:108927.
     PubMed     Abstract available
     
     
     
151. LI X, Huang B, Liu Y, Wang M, et al
     Uric acid in diabetic microvascular complications: Mechanisms and therapy.
     J Diabetes Complications. 2024;39:108929.
     PubMed     Abstract available
     
     
     
152. GEORGE BL, Perez AM, Rodriguez P, Parekh P, et al
     The association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier.
     J Diabetes Complications. 2024;39:108931.
     PubMed     Abstract available
     
     
     
153. HEINRICH NS, Pedersen RP, Vestergaard MB, Lindberg U, et al
     Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease.
     J Diabetes Complications. 2024;39:108923.
     PubMed     Abstract available
     
     
     
154. YARIBEYGI H, Maleki M, Forouzanmehr B, Kesharwani P, et al
     Exploring the antioxidant properties of semaglutide: A comprehensive review.
     J Diabetes Complications. 2024;38:108906.
     PubMed     Abstract available
     
     
     
155. GONZALEZ-VIDAL T, Rivas-Otero D, Ares-Blanco J, Lambert C, et al
     Real-life evaluation of consensus recommendations for transition to subcutaneous insulin in hyperosmolar hyperglycemic crises.
     J Diabetes Complications. 2024;38:108902.
     PubMed     Abstract available
     
     
     
156. HONG SH, Jee Y, Sung YA, Hong YS, et al
     Impact of visit-to-visit glycated hemoglobin variability on diabetes distress and its subscales.
     J Diabetes Complications. 2024;39:108924.
     PubMed     Abstract available
     
     
     November 2024
157. ZHENG Z, Cao B, Ke J, Zhao D, et al
     The effect of long-term glycemic burden on the incidence of diabetic foot ulcers: A retrospective study.
     J Diabetes Complications. 2024;39:108901.
     PubMed     Abstract available
     
     
     
158. YOKOMICHI H, Mochizuki M, Suzuki S, Ito Y, et al
     Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan.
     J Diabetes Complications. 2024;39:108922.
     PubMed     Abstract available
     
     
     
159. CARDOSO CRL, da Silva Pereira L, Leite NC, Salles GF, et al
     Prognostic importance of baseline and changes in serum uric acid for macro/microvascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort.
     J Diabetes Complications. 2024;39:108921.
     PubMed     Abstract available
     
     
     
160. ALFADDA AA, Alqutub AN, Sherbeeni SM, Aldosary AS, et al
     Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD.
     J Diabetes Complications. 2024;39:108910.
     PubMed     Abstract available
     
     
     
161. VARUGHESE MS, Nayak AU
     Diabetic macular edema: Variations in observations with intensive treatment optimizing glycemia.
     J Diabetes Complications. 2024;39:108909.
     PubMed    
     
     
     
162. WADA S, Iwanaga Y, Nakai M, Noguchi T, et al
     Stepwise cardiovascular risk stratification in patients with type 2 diabetes based on coronary CT assessment.
     J Diabetes Complications. 2024;39:108908.
     PubMed     Abstract available
     
     
     
163. PANTAZOPOULOS D, Gouveri E, Rizzo M, Papanas N, et al
     Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?
     J Diabetes Complications. 2024;38:108905.
     PubMed     Abstract available
     
     
     
164. ROONEY MR, Norby FL, Soliman EZ, Chen LY, et al
     Duration of diabetes, glycemic control, and low heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study.
     J Diabetes Complications. 2024;38:108903.
     PubMed     Abstract available
     
     
     
165. LAWRENCE CM, Smart CE, Fatima A, King BR, et al
     Increased bolus overrides and lower time in range: Insights into disordered eating revealed by insulin pump metrics and continuous glucose monitor data in Australian adolescents with type 1 diabetes.
     J Diabetes Complications. 2024;38:108904.
     PubMed     Abstract available
     
     
     
166. DIMOVA R, Chakarova N, Serdarova M, Tankova T, et al
     Lipid profile is similar in both subjects with high 1-hour postload glucose and 2-hour postload glucose and is related to cardio-metabolic profile in prediabetes.
     J Diabetes Complications. 2024;38:108869.
     PubMed     Abstract available
     
     
     
167. BAKER CJ, Min D, Marsh-Wakefield F, Siwan E, et al
     Circulating CD31(+) Angiogenic T cells are reduced in prediabetes and increase with exercise training.
     J Diabetes Complications. 2024;38:108868.
     PubMed     Abstract available
     
     
     October 2024
168. GOLBETS E, Sagy I, Ribak Z, Ben David R, et al
     Clinical features and outcomes of patients diagnosed with diabetic ketoacidosis (DKA) who were hospitalized for conditions outside of internal medicine.
     J Diabetes Complications. 2024;38:108900.
     PubMed     Abstract available
     
     
     
169. TSAI MH, Chien WC, Lin HC, Chung CH, et al
     Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin.
     J Diabetes Complications. 2024;38:108898.
     PubMed     Abstract available
     
     
     
170. HERDER C, Rizzo M, Roden M
     Precision diabetology: Where do we stand now?
     J Diabetes Complications. 2024 Oct 24:108899.
     PubMed    
     
     
     
171. STOUGAARD EB, Tougaard NH, Sivalingam S, Hansen CS, et al
     Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Study.
     J Diabetes Complications. 2024;38:108892.
     PubMed     Abstract available
     
     
     
172. HUANG C, Lin S, Yan Z, Yu W, et al
     Effects of moderate-intensity aerobic training on cardiac structure and function in type 2 mellitus diabetic rats: Based on echocardiography and speckle tracking.
     J Diabetes Complications. 2024;38:108896.
     PubMed     Abstract available
     
     
     
173. VARKEVISSER RDM, Sas T, Aanstoot HJ, Wolffenbuttel BHR, et al
     Residual C-peptide is associated with new and persistent impaired awareness of hypoglycaemia in type 1 diabetes.
     J Diabetes Complications. 2024;38:108893.
     PubMed     Abstract available
     
     
     
174. SHAKOUR N, Mahdinezhad MR, Asgharzadeh F, Khazaei M, et al
     Antioxidant effects of a novel pioglitazone analogue (PA9) in a rat model of diabetes: Modulation of redox homeostasis and preservation of tissue architecture.
     J Diabetes Complications. 2024;38:108897.
     PubMed     Abstract available
     
     
     
175. TENTOLOURIS A, Stefanou MI, Vrettou AV, Palaiodimou L, et al
     Prevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: A systematic review.
     J Diabetes Complications. 2024;38:108883.
     PubMed     Abstract available
     
     
     
176. CHEONG SS, Samah N, Che Roos NA, Ugusman A, et al
     Prognostic value of pulse wave velocity for cardiovascular disease risk stratification in diabetic patients: A systematic review and meta-analysis.
     J Diabetes Complications. 2024;38:108894.
     PubMed     Abstract available
     
     
     
177. DEFANTE MLR, de Souza MM, Mendes BX, De Hollanda Morais BAA, et al
     Subcutaneous rapid-acting insulin analogues in mild to moderate diabetic ketoacidosis: A meta-analysis of randomized controlled trials.
     J Diabetes Complications. 2024;38:108882.
     PubMed     Abstract available
     
     
     
178. PUTULA E, Kauppala T, Vanhamaki S, Haapakoski J, et al
     All-cause mortality and factors associated with it in finnish patients with type 1 diabetes.
     J Diabetes Complications. 2024;38:108881.
     PubMed     Abstract available
     
     
     
179. TU Q, Hyun K, Lin S, Hafiz N, et al
     Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study.
     J Diabetes Complications. 2024;38:108878.
     PubMed     Abstract available
     
     
     
180. HUANG JX, Casper TC, Pitts C, Myers SR, et al
     Characterizing the relationship between social determinants of health and risk of albuminuria among children with type 1 diabetes.
     J Diabetes Complications. 2024;38:108880.
     PubMed     Abstract available
     
     
     
181. FERREIRA-DIVINO LF, Poulsen CG, Rotbain Curovic V, Pedersen OB, et al
     Endothelial dysfunction markers syndecan-1 and thrombomodulin are associated with higher albuminuria levels in type 2 diabetes with no history of clinical cardiovascular disease.
     J Diabetes Complications. 2024;38:108879.
     PubMed     Abstract available
     
     
     
182. KOWALL B, Maier G, Rathmann W
     Too good to be true: Are GLP-1 receptor agonists the new metformin?
     J Diabetes Complications. 2024;38:108851.
     PubMed     Abstract available
     
     
     
183. CAO W, Zou J, Gao M, Huang J, et al
     A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-beta test.
     J Diabetes Complications. 2024;38:108831.
     PubMed     Abstract available
     
     
     
184. RIZOS EC, Ntzani EE, Rangraze IR, El-Tanani M, et al
     The importance of arterial stiffness in pediatric patients with type 1 diabetes mellitus: What's new?
     J Diabetes Complications. 2024;38:108877.
     PubMed     Abstract available
     
     
     September 2024
185. NANDAKUMAR D, Johnson MJ, Lavery LA, Conover BM, et al
     Lower extremity amputation rates in patients with chronic kidney disease: A database study comparing patients with and without diabetes mellitus.
     J Diabetes Complications. 2024;38:108876.
     PubMed     Abstract available
     
     
     
186. ALAN MS, Tayebi A, Afshar EJ, Alan SS, et al
     Association of detectable C-peptide levels with glycemic control and chronic complications in individuals with type 1 diabetes mellitus: A systematic review and meta-analysis.
     J Diabetes Complications. 2024;39:108867.
     PubMed     Abstract available
     
     
     
187. ZUNICA-GARCIA S, Javier Blanquer-Gregori JF, Sanchez-Ortiga R, Chicharro-Luna E, et al
     Association between Mediterranean diet adherence and peripheral artery disease in type 2 diabetes mellitus: An observational study.
     J Diabetes Complications. 2024;38:108871.
     PubMed     Abstract available
     
     
     
188. STANISZEWSKA A, Jones A, Rudd S, de Vocht F, et al
     Effectiveness of screening for foot complications in people with diabetes - A systematic review.
     J Diabetes Complications. 2024;38:108865.
     PubMed     Abstract available
     
     
     
189. JIANG Y, Wang X, Zhao X, Sun Y, et al
     The correlation between patients with type 2 diabetes mellitus and chronic microvascular complications during the glucose peak time.
     J Diabetes Complications. 2024;38:108866.
     PubMed     Abstract available
     
     
     
190. TEASDALE S, Dong X, Griffin A, Clark PJ, et al
     Glycogenic hepatopathy associated with hepatic steatosis in type 1 diabetes.
     J Diabetes Complications. 2024;38:108870.
     PubMed     Abstract available
     
     
     
191. DAMM JA, Dalgas-Madsen A, Hansen CS, Pilgaard KA, et al
     Presence of neuropathy in children and adolescents with type 1 diabetes evaluated with bedside modalities.
     J Diabetes Complications. 2024;38:108873.
     PubMed     Abstract available
     
     
     
192. CARDENAS-SALAS JJ, Sierra Poyatos RM, Luca BL, Sanchez Lechuga B, et al
     REAL life study of subcutaneous SEMaglutide in patients with type 2 diabetes in SPain: Ambispective, multicenter clinical study. Results in the GLP1-experienced cohort.
     J Diabetes Complications. 2024;38:108874.
     PubMed     Abstract available
     
     
     
193. FAVEL K, Bone JN, Elliott T, Panagiotopoulos C, et al
     Classification of longitudinal estimated glomerular filtration rate trajectories in Canadian adults with type 1 diabetes.
     J Diabetes Complications. 2024;38:108864.
     PubMed     Abstract available
     
     
     
194. DAVIS TME, Bruce DG, Schimke K, Chubb SAP, et al
     The inter-relationship between Helicobacter pylori infection, dementia and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase I.
     J Diabetes Complications. 2024;38:108854.
     PubMed     Abstract available
     
     
     
195. GOMEZ-GARCIA EF, Cueto-Manzano AM, Martinez-Ramirez HR, Cortes-Sanabria L, et al
     Dietary counseling, meal patterns, and diet quality in patients with type 2 diabetes mellitus with/without chronic kidney disease.
     J Diabetes Complications. 2024;38:108853.
     PubMed     Abstract available
     
     
     
196. KOLASA M, Arponen O, Kaartinen I, Saarinen E, et al
     Correlation of cerebral small vessel disease burden with outcome after lower extremity amputation.
     J Diabetes Complications. 2024;38:108829.
     PubMed     Abstract available
     
     
     August 2024
197. VUJOSEVIC S, Limoli C, Piccoli G, Costanzo E, et al
     A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography.
     J Diabetes Complications. 2024;38:108852.
     PubMed     Abstract available
     
     
     
198. ROKICKA D, Hudzik B, Wrobel M, Stoltny T, et al
     Prognostic value of novel atherogenic indices in patients with acute myocardial infarction with and without type 2 diabetes.
     J Diabetes Complications. 2024;38:108850.
     PubMed     Abstract available
     
     
     
199. GOLDNEY J, Barker MM, Thomas M, Slater T, et al
     Age at onset of type 2 diabetes and prevalence of vascular disease and heart failure: Systematic review and dose-response meta-analysis.
     J Diabetes Complications. 2024;38:108849.
     PubMed     Abstract available
     
     
     
200. GENG XF, Shang WY, Qi ZW, Zhang C, et al
     The mechanism and promising therapeutic strategy of diabetic cardiomyopathy dysfunctions: Focus on pyroptosis.
     J Diabetes Complications. 2024;38:108848.
     PubMed     Abstract available
     
     
     
201. EVIN F, Kirkgoz T, Atik T, Ak G, et al
     "Predicting diabetic kidney disease in youth with type 1 diabetes: Insights from genetic risk assessment".
     J Diabetes Complications. 2024;38:108833.
     PubMed     Abstract available
     
     
     
202. YI X, Pan Y, Peng H, Ren M, et al
     The optimal dose of metformin to control conversion to diabetes in patients with prediabetes: A meta-analysis.
     J Diabetes Complications. 2024;38:108846.
     PubMed     Abstract available
     
     
     
203. MOHLER R, Lotharius K, Moothedan E, Goguen J, et al
     Factors contributing to diabetic ketoacidosis readmission in hospital settings in the United States: A scoping review.
     J Diabetes Complications. 2024;38:108835.
     PubMed     Abstract available
     
     
     
204. XIE D, Yang K, Xu Y, Li Y, et al
     N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
     J Diabetes Complications. 2024;38:108801.
     PubMed     Abstract available
     
     
     
205. BILAL A, Yi F, Gonzalez GR, Ali M, et al
     Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysis.
     J Diabetes Complications. 2024;38:108783.
     PubMed     Abstract available
     
     
     July 2024
206. SARMA S, Hodzic-Santor B, Raissi A, Colacci M, et al
     Association of sodium glucose co-transporter-2 inhibitors with risk of diabetic ketoacidosis among hospitalized patients: A multicentre cohort study.
     J Diabetes Complications. 2024;38:108827.
     PubMed     Abstract available
     
     
     
207. JANUSZEWSKI AS, Grzelka-Wozniak A, Flotynska J, Jenkins AJ, et al
     An online tool using clinical factors to estimate the probability of partial clinical remission of adult-onset Type 1 diabetes.
     J Diabetes Complications. 2024;38:108828.
     PubMed     Abstract available
     
     
     
208. THYKJAER AS, Rosengaard L, Andersen N, Andresen J, et al
     Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study.
     J Diabetes Complications. 2024;38:108830.
     PubMed     Abstract available
     
     
     
209. ANITA NZ, Herrmann N, Ryoo SW, Major-Orfao C, et al
     Cytochrome P450-soluble epoxide hydrolase oxylipins, depression and cognition in type 2 diabetes.
     J Diabetes Complications. 2024;38:108826.
     PubMed     Abstract available
     
     
     
210. BENITES-MEZA JK, Malo-Castillo J, Herrera-Anazco P, Benites-Zapata VA, et al
     Atherogenic markers and 1-year amputation risk in adults with diabetic foot in a tertiary level hospital: A retrospective cohort study.
     J Diabetes Complications. 2024;38:108810.
     PubMed     Abstract available
     
     
     
211. GIANATTI E, Davis WA, Davis TME
     Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase II.
     J Diabetes Complications. 2024;38:108811.
     PubMed     Abstract available
     
     
     
212. PATOULIAS D, Karakasis P, El-Tanani M, Rizzo M, et al
     Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?
     J Diabetes Complications. 2024;38:108812.
     PubMed    
     
     
     
213. TASMAN J, Clegg DJ, Carver C, Adabala S, et al
     Assessing the influence of rural residence and economic distress on lower extremity risk stratification among diabetic foot ulcer patients utilizing the Wound, Ischemia, and Foot Infection (WIfI) classification system.
     J Diabetes Complications. 2024;38:108814.
     PubMed     Abstract available
     
     
     
214. VARGHESE NM, Varghese JS
     Sex differences in association of joint glycemic, blood pressure and lipid control and two-year risk of falls among older adults with diabetes.
     J Diabetes Complications. 2024;38:108815.
     PubMed     Abstract available
     
     
     
215. JOUNG KH, Kim TN, Ku EJ, Lee SS, et al
     A phase 4 randomized active-controlled clinical study to compare the efficacy and safety of sustained-release pregabalin with immediate-release pregabalin in type 2 diabetic patients with peripheral neuropathic pain.
     J Diabetes Complications. 2024;38:108809.
     PubMed     Abstract available
     
     
     
216. PHU A, Banghart M, Bahrainian M, Liu TYA, et al
     Dipeptidyl peptidase 4 inhibitors, sodium glucose cotransporter 2 inhibitors, and glucagon-like peptide 1 receptor agonists do not worsen diabetic macular edema.
     J Diabetes Complications. 2024;38:108808.
     PubMed     Abstract available
     
     
     
217. WANG Z, Crowe FL, Tahrani AA, Singh P, et al
     The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review.
     J Diabetes Complications. 2024;38:108813.
     PubMed     Abstract available
     
     
     
218. YAY F, Bayram E, Aggul H, Guclu CO, et al
     Can immature granulocytes and neutrophil-lymphocyte ratio be biomarkers to evaluate diabetic nephropathy?: A cross-sectional study.
     J Diabetes Complications. 2024;38:108807.
     PubMed     Abstract available
     
     
     
219. ZHANG X, Qiu W, Huang J, Pang X, et al
     Insulin combined with N-acetylcysteine attenuates type 1 diabetes-induced splenic inflammatory injury in canines by inhibiting the MAPKs-NF-kappaB signaling pathway and pyroptosis.
     J Diabetes Complications. 2024;38:108805.
     PubMed     Abstract available
     
     
     
220. LIAO M, Wang X
     Ameliorating effect of Chinese jujube polyphenol on blood glucose oxidative stress in type 2 diabetic rats.
     J Diabetes Complications. 2024;38:108804.
     PubMed     Abstract available
     
     
     
221. RIZOS EC, Tagkas CF, Asimakopoulos AI, Tsimihodimos V, et al
     The effect of SGLT2 inhibitors and GLP1 receptor agonists on arterial stiffness: A meta-analysis of randomized controlled trials.
     J Diabetes Complications. 2024;38:108781.
     PubMed     Abstract available
     
     
     June 2024
222. OLSEN MT, Klarskov CK, Hansen KB, Pedersen-Bjergaard U, et al
     Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumonia.
     J Diabetes Complications. 2024;38:108803.
     PubMed     Abstract available
     
     
     
223. DE PAULA AVL, Dykstra GM, da Rocha RB, Magalhaes AT, et al
     The association of diabetic peripheral neuropathy with cardiac autonomic neuropathy in individuals with diabetes mellitus: A systematic review.
     J Diabetes Complications. 2024;38:108802.
     PubMed     Abstract available
     
     
     
224. LUO Y, Qin Y, Kong L, Long J, et al
     Clinical and pathological characteristics of gestational diabetes mellitus with different insulin resistance.
     J Diabetes Complications. 2024;38:108796.
     PubMed     Abstract available
     
     
     
225. HERMANYI Z, Menyhart A, Korei AE, Istenes I, et al
     A comprehensive analysis of diabetic patient data before and during the COVID-19 pandemic - Lessons from the MERY diabetes database (MDD).
     J Diabetes Complications. 2024;38:108799.
     PubMed     Abstract available
     
     
     
226. POPOVIC DS, Patoulias D, Koufakis T, Stavropoulos K, et al
     Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?
     J Diabetes Complications. 2024;38:108800.
     PubMed     Abstract available
     
     
     
227. GOTTLIEB D, Abushamat LA, Nadeau KJ, Regensteiner JG, et al
     Muscle mitochondrial function is impaired in adults with type 1 diabetes.
     J Diabetes Complications. 2024;38:108798.
     PubMed     Abstract available
     
     
     
228. MUNDA A, Kovacic C, Pongrac Barlovic D
     Real-world data on the Minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy: One centre observational study.
     J Diabetes Complications. 2024;38:108795.
     PubMed     Abstract available
     
     
     
229. PORTERFIELD L, Yu X, Warren V, Bowen ME, et al
     A community health worker led diabetes self-management education program: Reducing patient and system burden.
     J Diabetes Complications. 2024;38:108794.
     PubMed     Abstract available
     
     
     
230. KOVOOR JG, Rayner CK, Wu T, Jalleh RJ, et al
     Effect of lixisenatide on liquid gastric emptying in type 2 diabetes - Implications for the use of GLP-1 receptor agonists before procedures.
     J Diabetes Complications. 2024;38:108793.
     PubMed     Abstract available
     
     
     May 2024
231. GEORELI E, Stamati A, Dimitriadou M, Chainoglou A, et al
     Assessment of arterial stiffness in paediatric patients with type 1 diabetes mellitus.
     J Diabetes Complications. 2024;38:108782.
     PubMed     Abstract available
     
     
     
232. SUZUKI T, Sato T, Tanaka M, Endo K, et al
     Tirzepatide ameliorates eating behaviors regardless of prior exposure to glucagon-like peptide receptor agonists in Japanese patients with type 2 diabetes mellitus.
     J Diabetes Complications. 2024;38:108779.
     PubMed     Abstract available
     
     
     
233. HALL RM, Marshall HJ, Parry-Strong A, Corley B, et al
     A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet.
     J Diabetes Complications. 2024;38:108778.
     PubMed     Abstract available
     
     
     
234. GATEVA A, Assyov Y, Karamfilova V, Kamenov Z, et al
     Common carotid artery intima media thickness (CIMT) in patients with prediabetes and newly diagnosed type 2 diabetes mellitus.
     J Diabetes Complications. 2024;38:108766.
     PubMed     Abstract available
     
     
     
235. SKRIVER-MOLLER AC, Moller AL, Blond MB, Rasmussen DGK, et al
     Extracellular matrix turnover proteins as risk markers in people with type 2 diabetes and microalbuminuria.
     J Diabetes Complications. 2024;38:108765.
     PubMed     Abstract available
     
     
     
236. BOOKER R, Wong M, Bancks MP, Carnethon MR, et al
     The longitudinal association of adipose-to-lean ratio with incident cardiometabolic morbidity: The CARDIA study.
     J Diabetes Complications. 2024;38:108725.
     PubMed     Abstract available
     
     
     
237. SHAPIRO ALB, Tjaden AH, Edelstein SL, Kahn SE, et al
     The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study.
     J Diabetes Complications. 2024;38:108764.
     PubMed     Abstract available
     
     
     April 2024
238. YAMADA E, Kajita R, Takahashi H, Horiguchi K, et al
     Exploring potential correlations between HLA class II and the risk of microvascular complications in Japanese patients with type 1 diabetes.
     J Diabetes Complications. 2024;38:108763.
     PubMed     Abstract available
     
     
     
239. HUANG JX, Copeland TP, Pitts CE, Myers SR, et al
     Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes.
     J Diabetes Complications. 2024;38:108762.
     PubMed     Abstract available
     
     
     
240. MIZRAK HI, Kufaishi H, Hecquet SK, Hansen TW, et al
     Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic.
     J Diabetes Complications. 2024;38:108761.
     PubMed     Abstract available
     
     
     
241. PETTY LD, Soto-Pedre E, McCrimmon RJ, Pearson ER, et al
     Body Mass Index's influence on arterial hypertension in Type 1 diabetes - A brief report from IMI-SOPHIA study.
     J Diabetes Complications. 2024;38:108747.
     PubMed     Abstract available
     
     
     
242. NOMURA K, Inagaki S, Muramae N, Takahashi H, et al
     Association of short-term changes in HbA1c with body composition and the importance of muscle maintenance in patients with Type 2 diabetes.
     J Diabetes Complications. 2024;38:108746.
     PubMed     Abstract available
     
     
     
243. KUFAISHI H, Mizrak HI, Brock B, Hansen TW, et al
     Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy - A Danes cohort study.
     J Diabetes Complications. 2024;38:108745.
     PubMed     Abstract available
     
     
     
244. ZHAO D, Ma J, Sun Y, Huang W, et al
     Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.
     J Diabetes Complications. 2024;38:108744.
     PubMed     Abstract available
     
     
     
245. XIE W, Hong Z, Li B, Huang B, et al
     Influence of glucagon-like peptide-1 receptor agonists on fat accumulation in patients with diabetes mellitus and non-alcoholic fatty liver disease or obesity: A systematic review and meta-analysis of randomized control trials.
     J Diabetes Complications. 2024;38:108743.
     PubMed     Abstract available
     
     
     
246. GRACIA-RAMOS AE, Cruz-Dominguez MDP, Madrigal-Santillan EO, Rojas-Martinez R, et al
     Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
     J Diabetes Complications. 2024;38:108742.
     PubMed     Abstract available
     
     
     
247. FILARDI T, Feraco A, Ouvrard-Pascaud A, Rizzo M, et al
     Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.
     J Diabetes Complications. 2024;38:108741.
     PubMed    
     
     
     
248. LASSCHUIT JWJ, Center JR, Greenfield JR, Tonks KTT, et al
     Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial.
     J Diabetes Complications. 2024;38:108718.
     PubMed     Abstract available
     
     
     
249. RAKOTOARISOA L, Weiss L, Lefebvre F, Porzio M, et al
     Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
     J Diabetes Complications. 2024;38:108703.
     PubMed     Abstract available
     
     
     March 2024
250. FARAH R, Alhajahjeh A, Al-Farahid O, Abuzaid H, et al
     Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification.
     J Diabetes Complications. 2024;38:108740.
     PubMed     Abstract available
     
     
     
251. SUN Q, Yang P, Gu QW, Gu WS, et al
     Increased glycemic variability results in abnormal differentiation of T cell subpopulation in type 2 diabetes patients.
     J Diabetes Complications. 2024;38:108738.
     PubMed     Abstract available
     
     
     
252. LIU F, You F, Yang L, Wang S, et al
     Metformin improves diabetic neuropathy by reducing inflammation through up-regulating the expression of miR-146a and suppressing oxidative stress.
     J Diabetes Complications. 2024;38:108737.
     PubMed     Abstract available
     
     
     
253. FONSECA LM, Kanapka L, Miller K, Pratley R, et al
     Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study.
     J Diabetes Complications. 2024;38:108739.
     PubMed     Abstract available
     
     
     
254. SANTOS EAM, Zaccara TA, Paganoti CF, Peres SV, et al
     Association between extrapolated time in range and large for gestational age infants in pregnant women with type 1 diabetes.
     J Diabetes Complications. 2024;38:108724.
     PubMed     Abstract available
     
     
     
255. PINES-CORRALES PJ, Lopez-Garcia MC, Sanz-Velasco A, Moya-Moya AJ, et al
     Changes in glucometric parameters in people living with diabetes users of the free-style libre 2 system before and after the update possibility to real-time glucose readings in real world practice.
     J Diabetes Complications. 2024;38:108723.
     PubMed     Abstract available
     
     
     
256. CAMPOS AC, Lima EG, Jacobsen PK, Arnould L, et al
     Association between obstructive coronary disease and diabetic retinopathy: Cross-sectional study of coronary angiotomography and multimodal retinal imaging.
     J Diabetes Complications. 2024;38:108721.
     PubMed     Abstract available
     
     
     
257. TSUR N, Frankel M, Cahn A, Tsur A, et al
     Gestational diabetes and risk of future diabetes in a multi-ethnic population.
     J Diabetes Complications. 2024;38:108720.
     PubMed     Abstract available
     
     
     
258. VUORLAAKSO M, Karen V, Kiiski J, Lahtela J, et al
     Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival.
     J Diabetes Complications. 2024;38:108719.
     PubMed     Abstract available
     
     
     February 2024
259. MATSUURA S, Nagata S, Shibazaki K, Uchida R, et al
     Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes.
     J Diabetes Complications. 2024;38:108717.
     PubMed     Abstract available
     
     
     December 2023
260. PATOULIAS D, Eid AH, Rizzo M
     Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus.
     J Diabetes Complications. 2023;37:108630.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.